共 29 条
[2]
BUCKLEY W R, 1973, Transactions of the St. John's Hospital Dermatological Society, V59, P39
[5]
Silver products for medical indications: Risk-benefit assessment
[J].
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY,
1996, 34 (01)
:119-126
[6]
Gulbranson SH, 2000, CUTIS, V66, P373
[7]
Hanada K, 1998, LANCET, V351, P960
[9]
HILL WR, 1939, ARGYRIA PHARM SILVER, P172
[10]
HILLWR, 1941, ARCH DERMATOL, V44, P588